Media Mentions 2015

December 2015

12/14/15 Konrad Hochedlinger, HSCI Principal Faculty member, identified a gene that when suppressed helps cells lose their "memory," making them more susceptible to reprogramming into iPS cells. 

Featured: Science 2.0, GEN NewsPhysOrgHNGNScience CodexNewsWise

12/03/15  HSCI Principal Faculty member George Daley provides expert commentary about the moral and ethical quandary of using gene-editing in human cells. 

FeaturedThe New York TimesThe Scientist

 

November 2015

11/23/15 The Boston Globe photographs HSCI co-founder and co-director Doug Melton at the Joslin Diabetes Center's16th annual High Hopes Gala. Melton received a Global Achievement Award that night. 

11/19/15 HSCI co-founder and co-director David Scadden speaks with CBS Chicago about the lack of scientific evidence and literature backing stem cell clinics and treatment centers. 

11/19/15 Boston Business Journal publishes a Q&A with HSCI co-founder and co-director Doug Melton, who received a Global Achievement Award from Joslin Diabetes Center in recognition of his contributions to the field of diabetes research. 

11/04/15 HSCI Principal Faculty member Paola Arlotta  reprograms neurons by turning one type of neuron into another type, and then shows that the way the new type of neurons communicate with their neuron neighbors can also change. 

FeaturedKurzweilAI NewsHarvard Gazette

 

October 2015

10/26/15 Work from HSCI researchers Konrad Hochedlinger and Peter Park compares embryonic stem cells and induced pluripotent stem cells to find if they are "functionally equivalent."

FeaturedPhys.orgBio EdgeGEN NewsScienceScience 2.0The ScientistThe San Diego Union-Tribune

10/26/15 Researchers, led by HSCI Principal Faculty member Joseph Bonventre, use genetically-engineered, mini-kidney  organdies to model genetic diseases. 

Featured: GEN NewsNews MedicalFuturity

 
10/18/15  HSCI researchers Joseph Bonventre, Albert Lam, and Todd Valerius created mature kidney structures from induced pluripotent stem cells. 

Featured: Bioscience TechnologyNews MedicalHarvard GazetteGizmodoLaboratory Equipment

10/01/15 In The Scientist, an article exploring adult humans' ability to generate new neurons features the work of HSCI Principal Faculty Amar Sahay.  

 

September 2015

09/28/15 European pharmaceutical company Roche Holding AG's collaborates with HSCI to screen for potential drugs to treat Autism. 

Featured: BloombergBusinessChicago Daily HeraldChicago Tribune

09/22/15 BBC News references HSCI Principal Faculty Member Harald Ott's work in an article about kidney regeneration. 

09/18/15 An article in the Boston Globe pictures HSCI Executive Director Brock Reeve, who sat on a panel about gene and cell therapies at the BioPharma America conference. 

09/02/15 An article published in the September issue of Discover Magazine features the work of HSCI Principal Faculty member Khalid Shah. 

09/02/15 Fox News article about stem cell tourism references a paper written and a panel organized by the Harvard Stem Cell Institute in 2013. 

 

August 2015 

08/12/15 Healthline News interviewed HSCI Principal Faculty member Jeff Karp about a hydrogel he invented that targets inflamed tissue and delivers drugs for those with inflammatory bowel disease. 

08/03/15 HSCI Principal Faculty member Olivier Pourquie's work generating muscle fibers to study muscular dystrophy is featured in Medical Daily.

 

July 2015

07/31/15 An article in The Scientist features the work of HSCI Affiliated Faculty member Luk Vandenberghe, who resurrected the structure of ancient viruses to help improve gene therapy. 

 

June 2015

06/03/15 News articles feature the work of HSCI Principal Faculty member Harald Ott, who has "grown" and transplanted muscle and vascular cells in a rat. 

 

 

May 2015

5/17/15 HSCI Principal Faculty member George Q. Daley comments on the ethics of stem cell clinics.

Featured: The Seattle TimesColumbus DispatchSan Jose Mercury NewsBoston Globe

 

 

April 2015 

04/20/15 HSCI Affiliated Faculty member Xiaoliang Sunney Xie is awarded the $500,000 Albany Medical Center Prize in Biomedicine and Biomedical Research.  Xie shares the prize with Standford University's Karl Deisseroth.

 

March 2015

03/24/15 The Boston Globe features Semma Therapeutics, a new biotech company commercializing research from  HSCI Co-founder and Principal Faculty member Doug Melton's lab. The company has raised $44 million to begin developing insulin-secreting cell transplant therapies for patients with Type 1 diabetes. 

03/13/15 Science news feature about eye transplants mentions HSCI Principal Faculty member Zhigang He's work on optic nerve regeneration. 

 

February 2015

02/26/15 In The Scientist, the latest work in the lab of HSCI Principal Faculty Jeff Karp (Brigham and Women's Hospital/Harvard Medical School) has important implications for improving the efficacy of mesenchymal stem cells (MSCs) used in clinical trials.

 

January 2015

01/21/15 Nature news feature on efforts to apply the findings of parabiotic research on mice to humans features HSCI Principal Faculty member Amy Wagers.